iSpecimen director Siyun Yang resigns from board

iSpecimen Inc. reported that Siyun Yang resigned from its Board of Directors effective February 17, 2026.

Rhea-AI Filing Summary

iSpecimen Inc. reported that Siyun Yang resigned from its Board of Directors effective February 17, 2026. The company stated that her resignation was not due to any disagreement regarding operations, policies, or practices.

Ms. Yang had served as an independent director since February 2025 and sat on both the Audit Committee and the Nominating and Corporate Governance Committee. iSpecimen thanked her for her service and expressed well wishes for her future endeavors.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What board change did iSpecimen (ISPC) disclose on February 17, 2026?

iSpecimen disclosed that director Siyun Yang resigned from its Board effective February 17, 2026. She had served since February 2025 and was a member of the Audit Committee and the Nominating and Corporate Governance Committee.

Did Siyun Yang resign from iSpecimen (ISPC) due to a disagreement?

According to the company, Siyun Yang’s resignation was not the result of any disagreement about iSpecimen’s operations, policies, or practices. The filing explicitly states there was no such dispute behind her decision to step down.

What committees did Siyun Yang serve on at iSpecimen (ISPC)?

Siyun Yang served as a member of iSpecimen’s Audit Committee and its Nominating and Corporate Governance Committee. These roles involve oversight of financial reporting, board nominations, and corporate governance matters within the company’s board structure.

How long did Siyun Yang serve on the iSpecimen (ISPC) board?

The filing notes that Siyun Yang had served as an independent director since February 2025. Her resignation became effective on February 17, 2026, indicating roughly one year of service on iSpecimen’s Board of Directors.

Who signed the iSpecimen (ISPC) report announcing Siyun Yang’s resignation?

The report was signed by Katharyn Field, iSpecimen’s Chief Executive Officer. Her signature on behalf of the company formally certifies the disclosure regarding director Siyun Yang’s resignation and related board and committee information.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/23/2026 - 04:30 PM EST Learn about SEC filing dates

false 0001558569 0001558569 2026-02-17 2026-02-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): February 17, 2026

iSpecimen Inc.

(Exact name of registrant as specified in its charter)

Delaware		001-40501		27-0480143
(State or other jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

8 Cabot Road, Suite 1800
Woburn, MA 01801

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (781) 301-6700

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		ISPC		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

On February 17, 2026, Ms. Siyun Yang resigned as a director of iSpecimen Inc. (the “Company”), effective immediately. Ms. Yang’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

Ms. Yang had served as an independent director since February 2025 and was a member of the Audit Committee and the Nominating and Corporate Governance Committee of the Board of Directors.

The Company extends its appreciation to Ms. Yang for her service and wishes her the best in her future endeavors.

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: February 23, 2026

iSPECIMEN INC.
By:	/s/ KATHARYN FIELD
	Name:	Katharyn Field
	Title:	Chief Executive Officer

2

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL SCHEMA FILE 2.9 KB
• EX-101 XBRL LABEL FILE 33.4 KB
• EX-101 XBRL PRESENTATION FILE 21.8 KB